4
Changes in Ownership
Protara Therapeutics, Inc. Filed Acc 0001209191-20-051631
Chief Financial Officer bought 1,481 shares at $16.91 ($25,038)
From the SEC's structured data for this filing
Trades in this filing
Davis Blaine · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-22 | Purchase : show line 1 in the form | +1,481 | $16.91 | $25,038 | 1,481 | D |
| Open-market purchases · 1,481 sh · avg $16.91 · $25,038 | ||||||
Loading xslF345X03/doc4.xml…